证券代码：300808 证券简称：久量股份 公告编号：2025-039 湖北久量股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 湖北久量股份有限公司（曾用名：广东久量股份有限公司，以下简称"公司"） 于 2025 年 6 月 18 日在巨潮资讯网（www.cninfo.com.cn）披露了《关于退回部 分政府补助的公告》（公告编号：2025-026）。在事后进行核查时发现，公司收 到十堰城市运营集团有限公司（以下简称"城运集团"）承诺承担政府补助退回 款时实际应将其计入资本公积-股本溢价科目，公司退回该款项至广州市政府相 关单位时实际应将其计入营业外支出科目，因此前述退回政府补助金事项应被认 定为关联交易。为保证公司信息披露的规范及完整，公司现将前述退回政府补助 金事项认定为关联交易，并按相关规定履行相应审议程序并对已披露公告进行相 应更正。本次更正不会对公司生产经营产生实质性影响，调整科目后对公司当期 损益有影响，对股东权益总额并无影响。具体更正内容详见后附对比表格。 公司因上述更正给投资者带来的不便深表歉意，敬请广大投资者谅解，公司 今后将进 ...

Core Viewpoint - The document provides a supplementary legal opinion regarding Shenzhen Magmi Electric Co., Ltd.'s application for a specific stock issuance, highlighting the company's financial performance, legal compliance, and the rationale behind its business operations and related transactions [1][2][3]. Financial Performance - The company's operating income for the reporting periods was 5,477.76 million yuan, with net profits of 479.39 million yuan, 625.11 million yuan, 458.69 million yuan, and 115.03 million yuan, showing a year-on-year decline of 18.39% in the most recent period [3]. - The company's main business gross profit margins were 23.57%, 24.54%, 25.07%, and 22.77%, indicating a competitive position in the smart home appliance and new energy vehicle sectors [3][4]. Cash Flow and Working Capital - The net cash flow from operating activities was negative in the reporting periods, attributed to increased cash payments for raw materials and slow customer payments, leading to a rise in accounts receivable [3][4]. - The company reported a significant increase in inventory, with a provision for inventory impairment of 86.45 million yuan, primarily due to an increase in outsourced processing scale [4][5]. Related Party Transactions - The company engaged in related party transactions with 14 entities, with significant transactions involving Anhui Magmi Electric, Xiamen Rongji, and Chongqing Senyate, which were deemed necessary and reasonable for business operations [13][20]. - The total amount of related party purchases and sales was relatively low, accounting for 1.46% to 1.00% of total sales, indicating limited reliance on related parties [18][20]. Legal Compliance and Risk Management - The legal opinion confirms that the company has adhered to relevant laws and regulations, ensuring that all financial statements and disclosures are accurate and complete [2][6]. - The company has implemented measures to mitigate risks associated with accounts receivable and inventory management, ensuring that provisions for bad debts are adequate [6][7]. Marketing and Sales Strategy - The company primarily utilizes direct sales, with marketing expenses for business promotion being approximately 4% of total sales expenses, reflecting a focus on industry exhibitions and online promotions [10][11]. - The marketing strategy has adapted to changes in the market environment, with a shift towards increased participation in industry exhibitions and a reduction in online promotional spending [10][11].

Core Viewpoint - The company plans to invest RMB 30 million in the Shanghai Haiwang Hezhong Private Equity Fund, which focuses on growth and mature enterprises in key industries such as integrated circuits, high-end manufacturing, and biomedicine, aligning with the company's main business [1][2][3] Investment Overview - The investment will be made as a limited partner (LP) in the Haiwang Hezhong fund, which has a total subscription amount of RMB 2.11 billion, with the company's contribution representing 1.4218% of the total [3][7] - The investment is intended to leverage the expertise and resources of professional investment institutions to optimize the company's investment structure and capture industry opportunities [2][15] Related Party Transactions - The investment involves a related party transaction as Shanghai Pudong Haiwang Private Fund Management Co., Ltd., the general partner (GP) of the fund, is associated with the company through an external director [1][4] - The transaction does not constitute a major asset restructuring as defined by regulations [1][4] Decision and Approval Process - The investment was approved by the company's board of directors and independent directors, with the related party abstaining from the vote, and does not require shareholder approval [2][17] - The independent directors believe the investment will enhance the company's ecological layout in the industry chain and is conducted on fair and reasonable terms [17] Fund Management and Structure - The fund will have a lifespan of 8 years, with a 5-year investment period followed by an exit period, during which the GP can extend the investment or exit periods under certain conditions [7][13] - The management fee for the fund is set at 2% per year, based on the partners' subscribed capital during the investment period [9][10] Financial Impact - The investment will not be consolidated into the company's financial statements and is expected to have no adverse impact on the company's operations or financial health [15][16] - The company will fulfill its capital contribution obligations as per the GP's payment notice [3][16]

招商证券股份有限公司 关于格兰康希通信科技（上海）股份有限公司 参与投资私募基金暨关联交易的核查意见 招商证券股份有限公司（以下简称"招商证券"或"保荐机构"）作为格兰 康希通信科技（上海）股份有限公司（以下简称"康希通信"或"公司"）首次 公开发行股票并上市持续督导的保荐机构，根据《证券发行上市保荐业务管理办 法》 《上海证券交易所科创板股票上市规则》 《上海证券交易所上市公司自律监管 指引第 11 号——持续督导》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相关法律、法规和规范性文件的规定，对康希通信参与投资 私募基金暨关联交易的事项进行了核查，具体情况如下： 一、参与投资私募基金暨关联交易概述 （一）基本情况 为借助专业投资机构的经验和资源，拓宽投资方式和渠道，把握公司所在行 业的投资机会，优化公司投资结构，实现产业协同。公司作为有限合伙人（LP） 参与投资上海海望合纵私募基金合伙企业（有限合伙） （以下简称"海望合纵"）。 公司拟以自有资金出资人民币 3,000.00 万元，出资金额占海望合纵总认缴出 资额的 1.4218%。 本次投资中公司未对其他投资人承诺保底收益或进行退 ...

Core Viewpoint - The company has renewed its financial services agreement with Fosun Finance Company, extending the service period from January 1, 2026, to December 31, 2028, to continue receiving non-exclusive financial services including comprehensive credit, deposits, and settlement [1][3][14] Summary by Relevant Sections Financial Services Agreement Overview - The new financial services agreement was signed on August 26, 2025, due to the expiration of the previous agreement, which was effective from January 1, 2023, to December 31, 2025 [1][3] - The agreement includes services such as comprehensive credit, deposits, and settlement, with a service period of three years [3][11] Related Party Transactions - Fosun Finance Company is considered a related party as it shares the same controlling shareholder, Fosun High Technology, with the company [1][4] - The renewal of the financial services agreement is classified as a related party transaction and requires approval from the company's shareholders [2][5] Purpose and Impact of Related Transactions - The agreement aims to enhance the efficiency of fund utilization, control financing costs, reduce financing risks, and improve deposit returns while ensuring that the interests of the company and minority shareholders are not compromised [2][12] - The fee standards for services provided will be equal to or better than those offered by other domestic financial institutions [2][12] Financial Projections and Limits - The expected transaction categories and annual limits under the new agreement include a daily maximum credit limit of RMB 200 million and a daily maximum deposit limit of RMB 200 million [4][9] - The company plans to apply for a maximum comprehensive credit limit of RMB 2 billion during the service period [8][9] Governance and Compliance - The renewal of the financial services agreement was approved by the board of directors, with related directors abstaining from the vote [5][6] - Fosun Finance Company is committed to maintaining operational compliance and ensuring the safety of funds deposited by the company [12][13]

Summary of Key Points Core Viewpoint - The company has renewed its product/service mutual supply framework agreement with Sinopharm Holdings, extending the agreement from January 1, 2026, to December 31, 2028, to support ongoing business needs [1][2]. Group Overview - The mutual supply framework agreement is essential for the company's operations, which span pharmaceutical manufacturing, medical devices, and healthcare services, creating a necessary and ongoing business relationship with Sinopharm Holdings [2][4]. Financial Data - The actual transactions between the company and Sinopharm Holdings for the years 2023, 2024, and the first half of 2025 are as follows: - Sales of raw materials or goods: 642,908,000 RMB in 2023, 557,908,000 RMB in 2024, and 292,003,000 RMB in the first half of 2025 - Purchases of raw materials or goods: 35,794,000 RMB in 2023, 45,187,000 RMB in 2024, and 21,991,000 RMB in the first half of 2025 - Provision of services: 93,000 RMB in 2023, 49,000 RMB in 2024, and 4,000 RMB in the first half of 2025 - Acceptance of services: 427,000 RMB in 2023, 179,000 RMB in 2024, and 121,000 RMB in the first half of 2025 [3][4]. Expected Transaction Limits - The expected transaction limits under the new framework agreement are as follows: - Sales of raw materials or goods: 1,100,000,000 RMB for 2026, 1,300,000,000 RMB for 2027, and 1,500,000,000 RMB for 2028 - Purchases of raw materials or goods: 80,000,000 RMB for 2026, 100,000,000 RMB for 2027, and 120,000,000 RMB for 2028 - Provision of services: 100,000 RMB for 2026, 120,000 RMB for 2027, and 150,000 RMB for 2028 - Acceptance of services: 2,000,000 RMB for 2026, 2,500,000 RMB for 2027, and 3,000,000 RMB for 2028 [4][5]. Approval Process - The renewal of the framework agreement requires approval from the company's shareholders after being reviewed and approved by the board of directors, excluding related directors [5][9].

证券代码 601857 证券简称 中国石油 公告编号 临 2025-020 中国石油天然气股份有限公司 第九届董事会第十四次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 中国石油天然气股份有限公司（以下简称公司）董事会于2025年8月 会议通知，会议于2025年8月26日在北京以现场及视频连线方式召开。应 出席会议董事11人，实际出席会议董事9人。董事任立新先生和谢军先生 因其他公务安排未能出席会议，分别书面委托董事黄永章先生和张道伟 先生代为出席并表决。会议由董事长戴厚良先生主持。部分监事和高级 管理人员列席了会议。本次会议符合《中华人民共和国公司法》和《中 国石油天然气股份有限公司章程》的规定，合法、有效。 二、董事会会议审议情况 公司董事审议了以下议案，并形成如下决议： （一）审议通过《关于公司2025年中期财务报告的议案》 （二）审议通过《关于公司2025年中期利润分配方案的议案》 议案表决情况：同意11票，反对0票，弃权0票。 本议案已经公司审计委员会审议通过，并同意提交董事会 ...

Core Points - The company held its 14th meeting of the 6th Board of Directors, where several key resolutions were passed, including the approval of the 2025 semi-annual report and amendments to the company’s articles of association [1][2][4] Group 1: Financial Reports and Amendments - The board approved the 2025 semi-annual report and its summary, with a unanimous vote of 9 in favor [1] - The company will no longer have a supervisory board, with its powers transferred to the audit committee of the board, following amendments to the articles of association [2] - The board also approved the revision and abolition of several management systems to align with the latest legal regulations [3][4] Group 2: Related Party Transactions and Guarantees - The company approved a plan for daily related party transactions for 2025, with a total expected amount not exceeding RMB 30 million for Wuhan Nanhua Industrial Equipment Engineering Co., Ltd. and other specified companies [4][5] - The board approved an increase in the external guarantee limit for 2025 to RMB 12 billion, raising the total expected external guarantee limit from RMB 3.4 billion to RMB 4.6 billion [5][6] Group 3: Financial Adjustments and Investments - The company will use its surplus reserves and capital reserves to cover cumulative losses amounting to RMB 1.29 billion [7] - The board approved the establishment of a partnership fund for the green smart shipping industry in Jiujiang City, with the company contributing RMB 9 million [8] Group 4: Upcoming Meetings - The company scheduled its first extraordinary general meeting for 2025 on September 11, 2025, with a registration date of September 5, 2025 [9]

Core Viewpoint - The company plans to acquire 97.4399% of Hangzhou Lipo Technology Co., Ltd. through a combination of issuing shares and cash payments, while also raising supporting funds through share issuance to specific management companies [1][2]. Group 1: Transaction Overview - The company’s board approved the transaction on August 7, 2025, and the first extraordinary general meeting of shareholders was held on August 22, 2025, to review the related proposals [2]. - The transaction involves 14 counterparties, including Wang Xulongqi and Deng Haoyu, who hold the majority shares of the target company [1]. Group 2: Updates and Revisions - The company updated the transaction documents due to a change in the review institution to Tianjian Accounting Firm, which issued a review report [2][3]. - The revised report includes updates on the decision-making and approval processes that still need to be fulfilled for the transaction [3][4]. Group 3: Compliance and Financial Information - The revised report also contains updates on the compliance analysis of the transaction and the financial accounting information as per the review report from Tianjian Accounting Firm [5][6]. - The company has conducted a thorough review and self-check of the entire restructuring report, ensuring that minor adjustments do not affect the transaction plan [6].

重大影响。 一、关联交易基本情况 （一）审议程序 证券代码：601077 证券简称：渝农商行 公告编号：2025-033 重庆农村商业银行股份有限公司 关于关联交易事项的公告 本行董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 六十次会议审议，同意对浙江网商银行股份有限公司（以下简称"浙江网商银行"） 给予同业综合授信额度 12 亿元，授信期限 1 年；同意向浙江网商银行支付贷款 服务费，关联交易金额不超过 3000 万元。以上关联交易金额合计不超过 12.3 亿元。 （二）关联关系及关联交易情况 本次关联交易定价依据市场原则，相关条件不优于本行对非关联方同类业务， 按照商业原则和一般商业条款或更佳条款进行，并符合本行定价政策。 四、关联交易的影响 本次关联交易为本行的正常业务，定价合理，符合监管要求及本行关联交易 管理相关规定，对本行正常经营活动及财务状况无重大影响。 本行第五届董事会第六十次会议审议通过了《关于审议浙江网商银行股份有 限公司授信类关联交易的议案》《关于审议浙江网商银行股份有限公司非授信类 关联交易 ...